Market Cap 325.40M
Revenue (ttm) 0.00
Net Income (ttm) -57.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 277,300
Avg Vol 495,026
Day's Range N/A - N/A
Shares Out 18.71M
Stochastic %K 38%
Beta 3.21
Analysts Strong Sell
Price Target $79.75

Company Profile

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treat...

Industry: Biotechnology
Sector: Healthcare
Phone: 339 666 3320
Address:
490 Arsenal Way, Suite 210, Watertown, United States
oreoPp
oreoPp Oct. 24 at 1:30 AM
$TECX yeah.
0 · Reply
oreoPp
oreoPp Oct. 22 at 3:55 PM
$TECX shorts working
0 · Reply
oreoPp
oreoPp Oct. 15 at 10:40 PM
$TECX is my short gonna. Work? Or go Woke.
0 · Reply
stocksense2
stocksense2 Oct. 15 at 5:51 PM
0 · Reply
JohnBoots
JohnBoots Oct. 15 at 3:41 PM
0 · Reply
Quantumup
Quantumup Oct. 14 at 11:11 AM
Mizuho $TECX OP-$85 $MRK $AZN Tectonic will present Phase 1b (Part B) hemodynamic data for TX45 in pulmonary hypertension patients with HFrEF (PH-HFrEF) in early 4Q25. We connected with Tectonic. Overall, management expects the hemodynamic effects for TX45 in PH-HFrEF to move in the same direction as what was observed in patients with PH-HFpEF (Part A), where PCWP (left-sided filling pressure), mPAP, PVR all declined meaningfully, and cardiac output increased. KOLs we consulted also expect HFpEF and HFrEF patients to exhibit a similar pulmonary hemodynamic profile. As such, we expect positive Part B data, with clinically meaningful hemodynamic improvements of 15-20% for PCWP and 15-20% for PVR in patients with CpcPH as well as potentially meaningful CO and SVR improvements for PH-HFrEF patients. With TECX trading $2.X-3 above cash, the potential blockbuster opportunity for TX45 in HFpEF remains significantly underappreciated and no value for PH-HFrEF is in the stock. Reiterate Outperform.
1 · Reply
Danyzinho29
Danyzinho29 Oct. 13 at 12:17 PM
$TECX LFG 🚀
0 · Reply
oreoPp
oreoPp Oct. 11 at 1:14 AM
$TECX up day. Down. Down day. Down. Let me guess. Results. Down day flush.
0 · Reply
oreoPp
oreoPp Oct. 9 at 6:22 PM
$TECX almost a million shares traded. Sell?
1 · Reply
oreoPp
oreoPp Oct. 9 at 1:06 AM
$TECX itch
0 · Reply
Latest News on TECX
Tectonic Therapeutic Joins Russell 3000® Index

Jun 30, 2025, 8:00 AM EDT - 4 months ago

Tectonic Therapeutic Joins Russell 3000® Index


Tectonic Announces $185 Million Private Placement

Feb 3, 2025, 6:30 AM EST - 9 months ago

Tectonic Announces $185 Million Private Placement


Tectonic Therapeutic: Protein Engineering Platform For GPCRs

Jan 5, 2025, 7:30 AM EST - 10 months ago

Tectonic Therapeutic: Protein Engineering Platform For GPCRs


Tectonic Therapeutic to Present Phase 1a Data at AHA 2024

Oct 22, 2024, 4:01 PM EDT - 1 year ago

Tectonic Therapeutic to Present Phase 1a Data at AHA 2024


Tectonic Therapeutic: Interesting CV Disease Drug Developer

Oct 20, 2024, 6:02 AM EDT - 1 year ago

Tectonic Therapeutic: Interesting CV Disease Drug Developer


oreoPp
oreoPp Oct. 24 at 1:30 AM
$TECX yeah.
0 · Reply
oreoPp
oreoPp Oct. 22 at 3:55 PM
$TECX shorts working
0 · Reply
oreoPp
oreoPp Oct. 15 at 10:40 PM
$TECX is my short gonna. Work? Or go Woke.
0 · Reply
stocksense2
stocksense2 Oct. 15 at 5:51 PM
0 · Reply
JohnBoots
JohnBoots Oct. 15 at 3:41 PM
0 · Reply
Quantumup
Quantumup Oct. 14 at 11:11 AM
Mizuho $TECX OP-$85 $MRK $AZN Tectonic will present Phase 1b (Part B) hemodynamic data for TX45 in pulmonary hypertension patients with HFrEF (PH-HFrEF) in early 4Q25. We connected with Tectonic. Overall, management expects the hemodynamic effects for TX45 in PH-HFrEF to move in the same direction as what was observed in patients with PH-HFpEF (Part A), where PCWP (left-sided filling pressure), mPAP, PVR all declined meaningfully, and cardiac output increased. KOLs we consulted also expect HFpEF and HFrEF patients to exhibit a similar pulmonary hemodynamic profile. As such, we expect positive Part B data, with clinically meaningful hemodynamic improvements of 15-20% for PCWP and 15-20% for PVR in patients with CpcPH as well as potentially meaningful CO and SVR improvements for PH-HFrEF patients. With TECX trading $2.X-3 above cash, the potential blockbuster opportunity for TX45 in HFpEF remains significantly underappreciated and no value for PH-HFrEF is in the stock. Reiterate Outperform.
1 · Reply
Danyzinho29
Danyzinho29 Oct. 13 at 12:17 PM
$TECX LFG 🚀
0 · Reply
oreoPp
oreoPp Oct. 11 at 1:14 AM
$TECX up day. Down. Down day. Down. Let me guess. Results. Down day flush.
0 · Reply
oreoPp
oreoPp Oct. 9 at 6:22 PM
$TECX almost a million shares traded. Sell?
1 · Reply
oreoPp
oreoPp Oct. 9 at 1:06 AM
$TECX itch
0 · Reply
oreoPp
oreoPp Oct. 7 at 2:59 AM
$TECX So it can be. Like. Phase 3 validation. TX45 phase 1b part b + AZD 3427 phase 2b. Combo. $SRRK Stars ⭐️ need to align Plus market sentiment and biotechs. perking up recently. + short int at 22%. + Springer to. Buy more. Could be. Explosive. 🧨
1 · Reply
oreoPp
oreoPp Oct. 7 at 2:47 AM
$TECX $SRRK If Tim Springer and Alise repeat again. It’s 10x given the suppressed market cap. $0 EV
0 · Reply
oreoPp
oreoPp Oct. 7 at 2:16 AM
$TECX where when October November
0 · Reply
oreoPp
oreoPp Oct. 5 at 3:15 PM
$TECX Fuel. It. Up. Light. It.
0 · Reply
oreoPp
oreoPp Oct. 3 at 7:11 PM
$TECX CEO. Said. WTF three times to $LLY just say it. Truthfully. I. Want. To. Buy. Tim. Springer. ‘S. Tectronic for $3 Billion.
0 · Reply
oreoPp
oreoPp Oct. 3 at 10:39 AM
$TECX this month to end of the year
0 · Reply
oreoPp
oreoPp Oct. 1 at 2:47 AM
$TECX 🔥🔥
0 · Reply
oreoPp
oreoPp Oct. 1 at 12:42 AM
$TECX now Oct
0 · Reply
oreoPp
oreoPp Sep. 25 at 11:11 AM
$TECX actual enrollment updated to 260 from 220 after LLY debacle 🧐
1 · Reply
ProfitMaker4
ProfitMaker4 Sep. 24 at 10:35 AM
$TECX started a position at these levels. Currently trading near BV, strong inst accumulation, and NT catalyst.
0 · Reply
oreoPp
oreoPp Sep. 23 at 5:18 AM
0 · Reply
Khanstocks
Khanstocks Sep. 18 at 6:23 PM
$TECX insiders has been an active buyer. Let’s see if he buys again will know shortly.
0 · Reply